Late Breaking Abstracts 2023
DOI: 10.1136/ejhpharm-2023-eahp.411
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-165 Adaptation of marketed parenteral nutrition to the needs of a hospital

Abstract: extend to a greater number of patients and include other drugs with adjustment to renal function. In order to validate the estimated renal function and understand which formula is closest to reality, it would be important to determine the measured GFR. Controversy remains as to whether adoption of eGFR for drug dosing is appropriate given that dosing recommendations for many available drugs are based on CG estimates of kidney function. Using the same kidney function estimate for management of kidney disease, d… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles